-
Je něco špatně v tomto záznamu ?
Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917
O. Dusek, A. Fajstova, A. Klimova, P. Svozilkova, T. Hrncir, M. Kverka, S. Coufal, J. Slemin, H. Tlaskalova-Hogenova, JV. Forrester, J. Heissigerova
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV17-31248A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-03-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
33375578
DOI
10.3390/cells10010023
Knihovny.cz E-zdroje
- MeSH
- autoimunitní nemoci terapie MeSH
- Escherichia coli * MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- probiotika * aplikace a dávkování farmakologie MeSH
- střevní sliznice patologie MeSH
- uveitida terapie MeSH
- zánět terapie MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Non-infectious uveitis is considered an autoimmune disease responsible for a significant burden of blindness in developed countries and recent studies have linked its pathogenesis to dysregulation of the gut microbiota. We tested the immunomodulatory properties of two probiotics, Escherichia coli Nissle 1917 (EcN) and E. coli O83:K24:H31 (EcO), in a model of experimental autoimmune uveitis (EAU). To determine the importance of bacterial viability and treatment timing, mice were orally treated with live or autoclaved bacteria in both preventive and therapeutic schedules. Disease severity was assessed by ophthalmoscopy and histology, immune phenotypes in mesenteric and cervical lymph nodes were analyzed by flow cytometry and the gut immune environment was analyzed by RT-PCR and/or gut tissue culture. EcN, but not EcO, protected against EAU but only as a live organism and only when administered before or at the time of disease induction. Successful prevention of EAU was accompanied by a decrease in IRBP-specific T cell response in the lymph nodes draining the site of immunization as early as 7 days after the immunization and eye-draining cervical lymph nodes when the eye inflammation became apparent. Furthermore, EcN promoted an anti-inflammatory response in Peyer's patches, increased gut antimicrobial peptide expression and decreased production of inducible nitric oxide synthase in macrophages. In summary, we show here that EcN controls inflammation in EAU and suggest that probiotics may have a role in regulating the gut-eye axis.
Centre for Experimental Immunology Lions Eye Institute Nedlands Western Australia 6009 Australia
Institute of Microbiology of the Czech Academy of Sciences v v i 142 20 Prague Czech Republic
Institute of Microbiology of the Czech Academy of Sciences v v i 549 22 Novy Hradek Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026326
- 003
- CZ-PrNML
- 005
- 20211026133003.0
- 007
- ta
- 008
- 211013s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cells10010023 $2 doi
- 035 __
- $a (PubMed)33375578
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Dusek, Otakar $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
- 245 10
- $a Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917 / $c O. Dusek, A. Fajstova, A. Klimova, P. Svozilkova, T. Hrncir, M. Kverka, S. Coufal, J. Slemin, H. Tlaskalova-Hogenova, JV. Forrester, J. Heissigerova
- 520 9_
- $a Non-infectious uveitis is considered an autoimmune disease responsible for a significant burden of blindness in developed countries and recent studies have linked its pathogenesis to dysregulation of the gut microbiota. We tested the immunomodulatory properties of two probiotics, Escherichia coli Nissle 1917 (EcN) and E. coli O83:K24:H31 (EcO), in a model of experimental autoimmune uveitis (EAU). To determine the importance of bacterial viability and treatment timing, mice were orally treated with live or autoclaved bacteria in both preventive and therapeutic schedules. Disease severity was assessed by ophthalmoscopy and histology, immune phenotypes in mesenteric and cervical lymph nodes were analyzed by flow cytometry and the gut immune environment was analyzed by RT-PCR and/or gut tissue culture. EcN, but not EcO, protected against EAU but only as a live organism and only when administered before or at the time of disease induction. Successful prevention of EAU was accompanied by a decrease in IRBP-specific T cell response in the lymph nodes draining the site of immunization as early as 7 days after the immunization and eye-draining cervical lymph nodes when the eye inflammation became apparent. Furthermore, EcN promoted an anti-inflammatory response in Peyer's patches, increased gut antimicrobial peptide expression and decreased production of inducible nitric oxide synthase in macrophages. In summary, we show here that EcN controls inflammation in EAU and suggest that probiotics may have a role in regulating the gut-eye axis.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a autoimunitní nemoci $x terapie $7 D001327
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 12
- $a Escherichia coli $7 D004926
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a zánět $x terapie $7 D007249
- 650 _2
- $a střevní sliznice $x patologie $7 D007413
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 12
- $a probiotika $x aplikace a dávkování $x farmakologie $7 D019936
- 650 _2
- $a uveitida $x terapie $7 D014605
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Fajstova, Alena $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
- 700 1_
- $a Klimova, Aneta $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Svozilkova, Petra $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
- 700 1_
- $a Hrncir, Tomas $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 549 22 Novy Hradek, Czech Republic
- 700 1_
- $a Kverka, Miloslav $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
- 700 1_
- $a Coufal, Stepan $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
- 700 1_
- $a Slemin, Johan $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
- 700 1_
- $a Tlaskalova-Hogenova, Helena $u Institute of Microbiology of the Czech Academy of Sciences, v.v.i., 142 20 Prague, Czech Republic
- 700 1_
- $a Forrester, John V $u Section of Immunology and Infection, Institute of Medical Sciences, University of Aberdeen, Aberdeen AB24 3FX, UK $u Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Crawley, Western Australia 6009, Australia $u Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia 6009, Australia
- 700 1_
- $a Heissigerova, Jarmila $u Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
- 773 0_
- $w MED00194911 $t Cells $x 2073-4409 $g Roč. 10, č. 1 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33375578 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133009 $b ABA008
- 999 __
- $a ok $b bmc $g 1715141 $s 1146833
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 1 $e 20201225 $i 2073-4409 $m Cells $n Cells $x MED00194911
- GRA __
- $a NV17-31248A $p MZ0
- LZP __
- $a Pubmed-20211013